GGrantIndex
Sort

166,118 grants matching stem cells

Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates

$816,856
Joren C Madsen · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · AI

Retinal tissue derived from human pluripotent stem cells for vision restoration

$816,848
Igor O. Nasonkin · Biotime, Inc. · R44 · FY2017 · EY

Emergency Myelopoiesis Pathways in the Control of Blood Production

$816,806
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2020 · HL

Emergency Myelopoiesis Pathways in the Control of Blood Production

$816,806
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2022 · HL

Emergency Myelopoiesis Pathways in the Control of Blood Production

$816,806
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2018 · HL

Emergency Myelopoiesis Pathways in the Control of Blood Production

$816,806
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2017 · HL

Emergency Myelopoiesis Pathways in the Control of Blood Production

$816,806
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2023 · HL

Emergency Myelopoiesis Pathways in the Control of Blood Production

$816,806
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2021 · HL

Emergency Myelopoiesis Pathways in the Control of Blood Production

$816,806
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2019 · HL

Discovering human divergent activity-regulated elements using comparative, computational, and functional approaches

$816,779
Alexander A Pollen · University Of California, San Francisco · R01 · FY2024 · MH

Discovering human divergent activity-regulated elements using comparative, computational, and functional approaches

$816,779
Alexander A Pollen · University Of California, San Francisco · R01 · FY2025 · MH

Structure and Function of Holliday Junctions complexed With Proteins Probed by Fluorescence and UV Raman Spectroscopic Methods

$816,749
Ishita Mukerji · Wesleyan University · · FY2009 · BIO

Systems genetics analysis of tumor evolution in the mouse

$816,707
Allan Balmain · University Of California, San Francisco · R35 · FY2025 · CA

Immune reconstitution following autologous and allogeneic stem cell transplant

$816,678
Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

Stem Cell Repair of Native Hearts in LVAD Patients

$816,675
Eric A Rose · Columbia University Health Sciences · P50 · FY2007 · HL

Synthetic PreImplantation Factor (sPIF) plus hypothermia to treat neonatal brain injury

$816,664
Eytan R Barnea · Bioincept, Llc · R44 · FY2025 · HD

Aberrant proteomes in tauopathy: revealing functional consequences via multimodal proteomics

$816,661
Danielle L Swaney · University Of California, San Francisco · R01 · FY2025 · AG

Autologous Lung Multipotent Stromal Cell Therapy for Emphysema

$816,611
Edward P Ingenito · Brigham And Women'S Hospital · R01 · FY2015 · HL

Protective Factors Against the Development of Microvascular Complications

$816,608
George L King · Joslin Diabetes Center · R24 · FY2010 · DK

Regulation Of Intracellular Iron Metabolism

$816,604
Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

Microglia targeted interventions in prodromal Alzheimer's disease stage

$816,586
Julia Tcw · Boston University Medical Campus · R01 · FY2024 · AG

Training in Environmental Toxicology

$816,534
B. Paige Lawrence · University Of Rochester · T32 · FY2016 · ES

Desmosomes in cardiomyocyte homeostasis and disease

$816,496
William T Pu · Boston Children'S Hospital · R01 · FY2023 · HL

Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma

$816,402
Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2016 · CA

Noninvasive measurement of oxygenation using quantitative susceptibility mapping

$816,383
Pascal Spincemaille · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL